Lilly files six lawsuits in bid to shut down ‘black market’ for retatrutide

Summary

Eli Lilly filed six lawsuits against sellers offering unauthorized versions of its experimental weight loss drug retatrutide ahead of its approval filing. The action is part of the company's effort to combat the black market for the highly anticipated 'triple-G' medicine.